Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Benchmarking and Identifying Opportunities to Improve Intentional Dose Non-Adherence in Clinical Trials

Session Chair(s)

Kenneth  Getz, MBA

Kenneth Getz, MBA

Tufts Center for the Study of Drug Development

Tufts University School of Medicine, United States

The results of a groundbreaking study quantifying intentional dose non-adherence are presented followed by a discussion among a panel of clinical and regulatory professionals on the implications of the findings.

Learning Objective : Quantify intentional dose non-adherence rates in clinical trials; Identify factors associated with, and predictive of intentional non-adherence; Discuss policies and solutions to address and reduce intentional non-adherence.

Speaker(s)

Kenneth  Getz, MBA

Quantifying the Magnitude of Intentional Dose Non Adherence

Kenneth Getz, MBA

Tufts University School of Medicine, United States

Tufts Center for the Study of Drug Development

Marlen  Rattiner, MA

Accounting For and Managing Dose Non-Adherence in Clinical Trials

Marlen Rattiner, MA

AiCure, United States

Vice President, Product Management

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.